Poster Abstract Submission Deadline September 17th.

About the Summit

Your Gateway to the International Stem Cell & Regenerative Medicine Community

The World Stem Cell Summit is the flagship international event uniting the stem cell community by bringing together scientists, patients, advocates, business people, investors, educators, ethicists, policy makers, government representatives, and others to network and learn from each other. In 2010, the Summit will attract more than 1,200 attendees from 30 nations, 60 exhibitors and more than 200 endorsing organizations and media partners from around the world.

Learn More >

Why Michigan?

Michigan’s world-class researchers and facilities, enthusiastic public support, commitment from public officials, and private philanthropic support make it an ideal host for the 2010 World Stem Cell Summit.

Michigan is fast becoming a biotechnology center. Academic institutions throughout the state house world-class researchers and facilities dedicated not only to fundamental stem cell research, but also to translating lab work into effective treatments and cures.

Learn More >

World Stem Cell Report

More than 40 articles and 200 pages of previously unpublished insight into the forefront of regenerative medicine.

 

Register before the early-bird deadline to guarantee your free copy of the 2010 World Stem Cell Report!

View the 2010 World Stem Cell Report Table of Contents

The editors of the 2010 World Stem Cell Report have invited more than 40 experts to share their views on regenerative medicine strategies in the regions of North and South America, Europe and the Asia Pacific region where stem cell research is on the forefront the biomedical research and commercialization agenda. The report will serve as a reference and guide to this diverse universe of organizations and networks that influence the pace and ultimate success in our field.

Register today to guarantee your copy of this unparalleled publication.

ADVERTISING OPPORTUNITIES ARE STILL AVAILABLE!
Complete this form to advertise in the World Stem Cell Report

CLICK HERE for advertising specifications.
AD SUBMISSION DEADLINE: August 13, 2010.

Stem Cell Action Awards Dinner

Tuesday Evening, October 5, 2010 - Detroit Marriot Renaissance Center, Columbus Ballroom

 

Join GPI in honoring the stem cell community’s top innovators, leaders, and champions at the 2010 Stem Cell Action Awards Dinner. Participate in the celebration as GPI recognizes the organizations and individuals who have had the most positive impact on the stem cell community.

The 2010 Honorees Include: Michigan Governor Jennifer M. Granholm (National Leadership Award); A. Alfred Taubman (National Advocacy Award); Stem Cell Network, Canada (Education Award); Stephen and Barbara Byer and ALS Worldwide (Grassroots Advocacy Award); Laura Jackson (Inspiration Award)
 
Support the stem cell community and RSVP today for the Stem Cell Action Awards Dinner

Learn more >

Who Attends

The 2010 World Stem Cell Summit will be the largest multi-track stem cell conference produced to date, featuring more than 150 speakers and 50 hours of in-depth science, business and society presentations. Attendees will include:

•    Scientists & Physicians
•    Regen Business Leaders
•    Investors
•    Policy Makers
•    Economic Dev Officers
•    Lawyers
•    Non-Profit Directors
•    Advocates/Patients
•    Media

Summit Agenda

Keynote Address - Robert Klein

Robert Klein, JD, conceived of, drafted and led the campaign to pass Proposition 71. The constitutional amendment authorized $3 billion in funding for embryonic and progenitor stem cell research in California and created the California Institute for Regenerative Medicine to distribute the funding. His visionary leadership has fostered important country and state collaborations. He is recognized throughout the world for his passion, leadership and advocacy. Full Agenda >

Industry Keynote Address - Thomas B. Okarma

Thomas B. Okarma, Ph.D., M.D., is the President, Chief Executive Officer of Geron Corporation, the iconic stem cell company that is conducting the first clinical trial approved by the FDA utilizing human embryonic stem cells for treatment of spinal cord injuries. Under his leadership, Geron has entered into impressive collaborations with G.E. Healthcare, Corning Corporation and others.  Full Agenda >

Science Track

Science Keynote Address—Dr. Sean Morrison, University of Michigan

As director of the University of Michigan Center for Stem Cell Biology, Dr. Sean Morrison is engaged in path finding research on mechanisms that regulate stem cell self-renewal, stem cell aging, and the relationship between stem cell self-renewal and cancer cell proliferation. He is a passionate advocate who played an instrumental role in the voter approval of Proposal 2, protecting stem cell research in the Michigan constitution. He is a Howard Hughes medical Institute investigator and an officer of the International Society for Stem Cell Research (ISSCR).

View the Science Track >

Industry Track

Industry Keynote Address - Thomas B. Okarma

Thomas B. Okarma, Ph.D., M.D., is the President, Chief Executive Officer of Geron Corporation, the iconic stem cell company that is conducting the first clinical trial approved by the FDA utilizing human embryonic stem cells for treatment of spinal cord injuries. Under his leadership, Geron has entered into impressive collaborations with G.E. Healthcare, Corning Corporation and others.

 

View the Industry Track >

 

Society Track

Risks and Rip-Offs: Where to Draw the Line on Stem Cell Tourism

The explosive growth of unregulated stem cell clinics in countries with unclear or lax regulation plus unsubstantiated patient testimonials on the Internet have become major societal concern. Patients are flocking for dubious treatments and are placing their health and financial security at risk. One such clinic was exposed in the dramatic “60 Minutes” piece entitled 21st Century Snake Oil and produced by CBS executive producer, David Gelber, whose work has earned an Emmy and Peabody awards. David will be a featured presenter at the World Stem Cell Summit along with Doug Sipp of the RIKEN Institute and patient-advocate, Stephen Byer on the panel “Risks and Rip-Offs: Where to Draw the Line on Stem Cell Tourism” on Wednesday, October 6. 
View the Society Track >